Eye cancer survivors: does treatment choice impact Long-Term happiness?
NCT ID NCT03662776
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times
Summary
This study looks at children and teens who survived retinoblastoma in one eye. Researchers want to see if those who had chemotherapy injected into the eye artery have a different quality of life than those who had the eye removed. Participants and their parents will fill out surveys about emotional and behavioral health. The goal is to learn which treatment may lead to better long-term well-being.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors choose treatments that better preserve quality of life for children with retinoblastoma.
- What could go wrong
- This is an observational study, not a treatment trial. It only looks at past treatments and cannot prove cause and effect. Results may not apply to all survivors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SURVIVORS OF UNILATERAL RETINOBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Texas Children's Hospital (Data Collection)
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.